https://pmc.ncbi.nlm.nih.gov/articles/PMC11507497/

Abstract

This paper takes the blood-drawing venous needle as a typical type of medical device and deeply analyzes its complete manufacturing and quality control process within the modern ISO13485 quality management system framework. From design input to product release, it elaborates on the key control points, risk management, and document requirements at each stage, revealing the rigorous logic and safety guarantee essence of compliant medical device production.

Introduction

In the medical field, the safety and effectiveness of products are closely linked to the reliability of the manufacturing process. A seemingly simple venous blood-drawing needle, its production process is far from being a simple metal processing. Based on ISO13485:2016 "Medical Devices - Quality Management System - Requirements for Regulatory Purposes," the entire process quality management system is constructed, which is the core framework for ensuring its stable performance and compliance with regulations. This analysis will penetrate the "production" surface and delve into the core of its quality control.

Design and Development Control: Quality Originates from Design

Manufacturing is not the starting point. Under the ISO13485 framework, design and development is the primary and crucial stage. For blood-letting needles, in this stage, the following needs to be clarified:

• User requirements and regulatory input: including puncture depth, blood flow rate, patient pain sensation, aseptic guarantee level, biocompatibility, and requirements from various national drug regulatory authorities (such as China's NMPA, the US FDA, and the EU MDR).
• Design output: transformed into specific product specifications, such as materials (such as stainless steel 316), dimensions (length, diameter/needle size), needle tip geometry (such as lancet style, multi-point style), lubrication coating, initial packaging method, etc.
• Risk management and verification: risk management is conducted in accordance with ISO14971 standards, identifying all potential hazards from material toxicity, needle injury to packaging failure, and taking control measures. The design needs to be confirmed through prototype testing, functional verification, and clinical evaluation (if necessary).

Procurement and Incoming Material Control: The Defense Line of the Supply Chain

The quality of the blood-drawing needle begins with the raw materials. The system requirements are:

• Qualified Supplier List: Conduct strict evaluations and audits of suppliers of stainless steel wires, plastic parts, packaging materials, etc., to ensure they possess the necessary qualifications and quality assurance capabilities.
• Incoming Inspection: For each batch of incoming materials, verify the material certificates, performance reports, and conduct random inspections or full inspections of key items such as size, hardness, surface finish, and cleanliness. Only qualified materials can be stored and put into production.

Process Control in Production: Standardization and Traceability

The production process is the core for achieving quality, and it must be under controlled conditions:

• Environmental Control: The production workshop, especially the later assembly and packaging areas, must have corresponding cleanliness levels, control temperature, humidity, and particles to prevent contamination.
• Process Validation: Conduct process validation for key procedures such as needle drawing, needle tip grinding, dispensing assembly, and sterilization to determine and fix the optimal process parameters, ensuring continuous and stable production of qualified products.
• Equipment and Identification: Equipment is regularly maintained and calibrated. Product batches are clearly marked to achieve full traceability from raw materials to finished products. This is one of the core requirements of ISO13485, facilitating quick identification and recall in case of problems.
• Process Inspection: Set up online inspection points (such as needle tip sharpness, size, and appearance) to promptly detect and eliminate non-conforming products.

Sterilization and Packaging: The Final Barrier for Safe Delivery

For the sterile blood-drawing needles provided, sterilization is a specific process:

• Sterilization process verification: Using methods such as ethylene oxide (EO) or irradiation, strict installation verification, operation verification, and performance verification are required to ensure the sterilization effect and material compatibility.
• Primary packaging verification: The packaging material must be able to maintain a sterile barrier and undergo verification such as transportation simulation and aging to ensure that the product remains sterile within the valid period and under the specified storage and transportation conditions.
• Sterility testing: Each sterilization batch must undergo sterility testing according to standards.

Final Inspection and Release: Quality Guardian

The finished products need to undergo final inspection, which includes but is not limited to:

• Performance testing: puncture force, flowability, breaking force, etc.
• Biocompatibility evaluation: The final product or its materials are tested according to the standards.
• Document review: The quality assurance department needs to review all the records from design, procurement, production, inspection to sterilization for this batch, ensuring compliance with the quality plan and regulatory requirements before signing the release report and allowing it to be marketed.

Conclusion

A modern venous bloodletting needle produced in accordance with ISO13485 standards is the result of "systematic manufacturing." Its value lies not only in its precise physical structure but also in the quality management network behind it, which defines, controls, records, and verifies every step from design to delivery. This systematic control minimizes medical risks, provides fundamental institutional guarantees for patients' medical safety, and constitutes the cornerstone of trust in the modern medical device industry.